Unexpected weight gain while taking Zepbound consistently requires investigation
Liu, C., Kou, Y., Zhang, X., Cheng, H., Chen, X
Many will suggest continuing the medication for maintenance, at least for a while [utswmed.org]
Its not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Reviews on the topic highlight that while clinical trials are essential to ensure a drug's safety and performance prior to widespread (routine) administration, their inherent rigidity in participant selection leaves critical gaps regarding how these medications perform in routine clinical practice, especially among elderly or frail patients and similar high-risk populations
10.1021/tx700235t 50 LieblerD